Keyword [Drug Design]
Result: 41 - 60 | Page: 3 of 10 |
| 41. | Structure-based Drug Design And Two Kinds Of Small Organic Molecules Catalyzed Ractions |
| 42. | Computational Study On Natural Compound Inhibitors Of Type A H1N1Influenza Virus Neuraminidase |
| 43. | Study On The Design, Screening And Evaluation Of D2X4 Receptor Antagonist |
| 44. | Phospholipase A 2 And Sphingomyelin Synthase Bifunctional Inhibitors In The Design, Synthesis And Activity Evaluation |
| 45. | Dual - Effect Dopamine Receptor Inhibitor Design And Multi - Target Recognition Method Validation |
| 46. | Study On The Design, Synthesis And Activity Of Novel β - Adenosine - Adrenergic Receptor Agonists |
| 47. | Study On The Design, Synthesis And Antitumor Activity Of 4 - Substituted All - Trans Retinoic Acid Compounds |
| 48. | Study On Pharmacophore Model Of Aldose Reductase Inhibitors |
| 49. | Study On Computer-aided Design For Cyclooxygenase-2(COX-2) Inhibitors |
| 50. | The Study Of Relationships Between Bioavialability And Structure Parameters Using Neural Network |
| 51. | The Research Of Some Carbohydrate Binding Protein And Ser/Thr Protein Phosphatase Using Computer Aided Drug Design Method |
| 52. | Computer-Aided Drug Design And Partial Synthesis Of Novel VEGF Receptor Inhibitors |
| 53. | A Methodological Study Of De Novo Drug Design |
| 54. | Design, Synthesis And Preliminary Activity Assay Of Pyrrolidines MMPIs |
| 55. | The Design, Synthesis And Preliminary Activity Assay In Vitro Of AHPA Derivatives As APN Inhibitors |
| 56. | The Design, Synthesis And Preliminary Activity Assay In Vitro Of L-iso-Glutamine Derivatives As APN Inhibitors |
| 57. | Synthesis Of Isosorbide Mononitrate Derivatives And 4,4'-dihydroxybenzophenone |
| 58. | Design And Synthesis Of Matrix Metalloproteinases-2,9 Inhibitors Based On Computer-Aided Drug Design |
| 59. | Design, Synthesis And Preliminary Activity Assay In Vitro Of L-Lysine Derivatives As APN Inhibitors |
| 60. | Research On Computer-Aided Drug Design, Synthesis And Initial Activity Evaluation Of γ-Secretase Inhibitors With Neuroprotective Effect |
|
